ENHERTU® Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial
Data support ongoing discussions with global health authorities TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Topline results…